Major Adverse Cardiovascular Events after Treatment in Early-stage Breast Cancer Patients Receiving Hormone Therapy

This nationwide population-based study investigated the differences in the risks of major adverse cardiovascular events (MACEs) among patients with hormone receptor–positive early-stage breast cancer undergoing different combinations of adjuvant treatments in Taiwan. Data from the National Health In...

Descripción completa

Detalles Bibliográficos
Autores principales: Chou, Ying-Hsiang, Huang, Jing-Yang, Kornelius, Edy, Chiou, Jeng-Yuan, Huang, Chien-Ning
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989448/
https://www.ncbi.nlm.nih.gov/pubmed/31996695
http://dx.doi.org/10.1038/s41598-020-57726-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989448/
https://www.ncbi.nlm.nih.gov/pubmed/31996695
http://dx.doi.org/10.1038/s41598-020-57726-z

Ejemplares similares